Author

Brion Randolph

Observed names: Brion V. Randolph, Brion Vincent Randolph

Institution: University of Tennessee Health Science Center

Observed institutions: St. Jude Children's Research Hospital, The University of Texas MD Anderson Cancer Center, Medical University of South Carolina, University of Tennessee Health Science Center, Cancer Treatment Centers of America, MUSC Hollings Cancer Center, Methodist University Hospital, Southeastern Health

OpenAlex ID: A5016373502

Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations

2018 · Stefan O. Ciurea, Abhishek Chilkulwar, et al. · Blood · 97

NK cell therapy for hematologic malignancies

2018 · Rohtesh S. Mehta, Brion Randolph, et al. · International Journal of Hematology · 89

NCCN Guidelines® Insights: Hematopoietic Cell Transplantation, Version 3.2022

2023 · Ayman Saad, Alison Loren, et al. · Journal of the National Comprehensive Cancer Network · 23

Hematopoietic Cell Transplantation, Version 3.2025, NCCN Clinical Practice Guidelines In Oncology

2025 · Alison W. Loren, Marco Mielcarek, et al. · Journal of the National Comprehensive Cancer Network · 13

Fresh Versus Cryopreserved Peripheral Stem Cell for Autologous Transplantation in Multiple Myeloma: An Analysis of Short-Term Outcomes

2020 · Jacinth Joseph, Vanessa Wookey, et al. · Blood · 5

What the Intensivist Needs to Know About Hematopoietic Stem Cell Transplantation?

2019 · Brion V. Randolph, Stefan O. Ciurea · Springer eBooks · 5

Foundation-OneR-Heme Next Generation Sequencing of Hairy Cell Leukemia Variant Lymphocytes

2016 · John R. Pawloski, Brion Randolph, et al. · Blood · 3

Engaging Underrepresented Patients in Hematology Clinical Trials through the LLS Impact (Influential Medicine Providing Access to Clinical Trials) Research Grant: A Multi-Institutional Effort

2023 · Eden Ayele Biltibo, Zachary Copeland, et al. · Blood · 2

What the Intensivist Needs to Know About Hematopoietic Stem Cell Transplantation?

2026 · Pongthep Vittayawacharin, Brion V. Randolph, et al. · Springer eBooks · 1

Chive-Impact: Establishing the Clonal Hematopoiesis and Inflammation in the Vasculature (CHIVE) Registry and Biorepository in Underserved Areas

2024 · Ashwin Kishtagari, Zachary Copeland, et al. · Blood

Comprehensive Analysis of Structural and Social Determinants of Health Leading to Delays in Seeking Hematologic Care: Survey of an Underserved Population with Hematologic Malignancies

2023 · Laura Quillen, Noura Elsedawy, et al. · Blood

Autologous Anti-CD19 CAR T Cells as Therapy for Systemic Lupus Erythematosus

2023 · Marko Radic, Brion Randolph · Transplantation and Cellular Therapy

Outcomes of AML Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation with Adverse Risk Disease By European Leukemianet Classification: A Single Center Retrospective Analysis

2019 · Zane Chiad, Clark Alsfeld, et al. · Blood

What the Intensivist Needs to Know About Hematopoietic Stem Cell Transplantation?

2019 · Brion V. Randolph, Stefan O. Ciurea · Springer eBooks

Chronic Lymphocytic Leukemia with Deletion 13q: Prognostic Predictors and Outcome after Treatment with Fludarabine, Cyclophosphamide and Rituximab (FCR)

2017 · Abdul Rashid Shah, Tariq Muzzafar, et al. · Blood

The role of next-generation sequencing (NGS) to integrate identified genomic alterations (GA) into cancer treatment decisions in gastrointestinal (GI) tumors.

2014 · Madappa N. Kundranda, Donald Peter Braun, et al. · Journal of Clinical Oncology

Works count: 16

Citation count: 238

H-index: 5

I10-index: 4